The initial goal of the Chemical Biology & Molecular Medicine Program (CBMM) is to integrate chemical biology, genomics, and molecular imaging to develop new therapeutic approaches for cancer. Initially, the program aims to:
- Identify, validate and characterize molecular targets and actionable deregulated pathways with therapeutic relevance in subsets of human cancer.
- Design small molecule chemical probes to modulate such molecular targets and deregulated pathways.
- Identify novel biomarker strategies using proteomics, genomics and molecular imaging to guide clinical decision making.
- Develop and implement mechanism-based therapeutic clinical trials.
Eric B. Haura, MD
Saïd Sebti, PhD